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ABSTRACT 
Over the Counter Liquid Bandage Application Results in Precocious Wound Closure Following 
Distal Amputation of the Terminal Phalangeal Digit in Mice 
Jacob Beattie 
Department of Biomedical Engineering 
Texas A&M University 
Sabeeha Tabassum 
Department of Health and Kinesiology 
Texas A&M University 
Dr. Ken Muneoka 
Department of Veterinary Physiology and Pharmacology 
Texas A&M University 
CVS Liquid Bandage -- a “value brand” version of wound closure devices such as 
Dermabond -- following a distal, P3 amputation in mice initiates precocious wound closure; 
inducing a hypoxic microenvironment, and/or leading to reduced regeneration of the P3 digit. 
Previous research has shown that epidermal closure and a hypoxic environment are 
crucial in mammalian regeneration; this study looks to confirm and expand this knowledge and 
potentially lead to new discoveries through the use of different immunohistochemical assays: 
Hif1α, and Hypoxyprobe for hypoxia and EdU as a marker for cell proliferation. 
It is expected that the CVS Liquid Bandage will induce similar results to those produced 
by application of Dermabond: premature wound closure, creation of a hypoxic 
microenvironment, reduced degeneration and regeneration, and a similar expression pattern from 
the immunohistochemical assays. 
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NOMENCLATURE 
DPA Days Post Amputation 
CVS-LB CVS Liquid Bandage 
P3 Terminal Phalanx 
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CHAPTER I 
INTRODUCTION 
Currently one out of 200 Americans is an amputee. In total, more than 1.7 million people 
are living with limb loss in the United States and this number is projected to double by 2050, 
reaching an upwards of 3.6 million. Vascular diseases, cancer, and trauma are among the leading 
causes of death of both lower and upper extremity amputations (Ziegler-Graham 2008). 
Mortality rates for amputees suffering from vascular diseases have increased to 43-55%, now 
higher than the five-year rates for breast, colon, and prostate cancer (Robbins et al. 2008). 
Although prosthetic technology has advanced significantly, amputees report their 
prostheses are often underutilized (Østlie et al. 2012). Despite the limitations of prosthetics, few 
other treatment options remain for those living with limb loss. Thus, studies in mammalian 
regeneration seek to discover a more viable and long term solution to help amputees restore 
motility and normalcy in their lives. 
A Brief Survey of Vertebrate Regenerative Capabilities 
While regenerative medicine will fill an important niche in the medical industry, it is 
clear that more research needs to be conducted before it becomes a viable option. Current 
research extensively uses animal models, with model organisms specifically chosen to cater to 
regenerative potential. For example, amphibians exhibit extensive regenerative capabilities, with 
many species able to successfully regenerate entire limbs (Goss 1969; Wallace 1981). However, 
neither humans nor any other mammalian species have shown the capacity for such regenerative 
ability; mammalian regeneration is limited to distal amputations of the third phalange (P3) that 
leave the nail organ intact (Borgens 1982; Neufeld & Zhao 1995; Han et al. 2008; Fernando et al. 
2011, Chamberlain et al. 2017). Due to the differences in regenerative scope, amphibian 
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regeneration is not currently a high quality model to use for studying human regeneration. 
However, mice experience analogous regeneration in comparison to humans, particularly in 
regards to distal P3 amputations (Han et al. 2008). Accordingly, mice provide an excellent model 
for pre-clinical studies and were used in this study. 
Overview of P3 Regeneration in Mice 
The regenerative process following a distal P3 amputation in mice can be summarized 
into several phases: inflammation/histolysis, wound closure, blastema formation, regeneration, 
and finally redifferentiation (Simkin et al. 2013). In non-experimental cases, the 
inflammation/histolysis stage seems to be initiated by the remaining epidermis attaching to the 
bone stump created by the amputation. Large, multinucleated osteoclasts then form and degrade 
the bone stump for several days, creating a secondary amputation plane. Epithelial wound 
closure occurs and blastema formation begins at the distal end of the secondary amputation 
plane. The wound closure event-which generally occurs between 8 and 12 DPA - seems to 
demarcate the end of the degenerative aspect of the wound healing response and the beginning of 
the regenerative phases (Fernando et al. 2011). The regenerative phase is characterized by the 
formation of a blastema, a mass of undifferentiated, lineage-dependent cells and is responsible 
for the proliferative aspect of the regeneration response which will ultimately differentiate into a 
complete regenerate. 
Although these phases have been relatively well characterized, the factors that delineate 
and trigger one phase leading to another have yet to be fully elucidated. It is in this light that we 
are investigating the effects of the wound closure product CVS brand liquid bandage (CVS-LB) 
on mammalian digit tip regeneration and comparing it to the effects of the previously-tested 
wound closure product Dermabond. Both CVS-LB and Dermabond are antiseptic wound closure 
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agents but have different methods of action: Dermabond employs the monomeric 2-octyl 
cyanoacrylate, which polymerizes within minutes of application, whereas CVS-LB employs 
eight active and inactive ingredients; of note, the ingredient nitrocellulose has previously been 
associated with accelerated wound closure and enhanced wound re-epithelialization (Xiafeng et 
al. 2016). Specifically, the influence of CVS-LB on epidermal wound closure and oxygen levels 
within the tissue was examined, as it has been thought that wound closure marks the end of the 
degradational phase and the advent of the regenerative phase in amputated digits. Normally, 
epidermal closure is completed between 8 and 12 DPA (Fernando et al. 2011), with a significant 
spike in hypoxia in the bone marrow at 7 DPA and in the blastema at 12 DPA (Sammarco et al. 
2014). However, it is highly likely that oxygen levels regulate the level of distal bone 
degradation in the P3 digit and associated with a reduction in subsequent regeneration (Simkin et 
al. 2015). We seek to confirm, and potentially expand on, the findings of that project by also 
using the wound closure agent Dermabond (2-octyl cyanoacrylate), which was utilized by 
Simkin et al. in her previous study, as a positive control for premature wound closure. 
Effects of Hypoxia and Wound Closure on Regeneration in Mice 
Oxygen tensions vary throughout the reparative process. Although normoxia is ultimately 
required for proper wound healing, a brief hypoxic microenvironment can initiate necessary 
processes such as angiogenesis and fibroblast growth through activation of HIF-1α, a master 
regulator of the adaptive responses responsible for normalizing oxygen levels (Hong et al. 2014). 
During inflammation/histolysis, the wound site becomes increasingly hypoxic due to lesioned 
vasculature and the arrival of metabolically demanding inflammatory cells, limiting oxygen 
availability and delivery. A hypoxic microenvironment can be observed within the marrow 
throughout the degradative phase. In the concluding stages of digit regeneration, regions of 
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hypoxia are only visible in the vasculature along the regenerated structure as well as in the 
trabecular bone (Sammarco et al. 2014; Simkin et al. 2015). 
The timing of wound closure has a major impact on the overall degree of regeneration. 
When wound closure is immediate - suturing of the skin flaps over the wound immediately 
following amputation - there is a complete lack of a regenerative response (Douglas, 1972; 
Mescher, 1976). Simkin et al. 2015 demonstrated that normal wound closure is regulated, at least 
partially, by the degree of oxygen saturation in the microenvironment of the wound site. 
Application of a wound closure agent, such as Dermabond, causes this microenvironment to 
become hypoxic earlier than normal which leads to accelerated wound closure, and the 
premature wound closure results in an abbreviated histolytic phase which alters the overall 
regenerative process (Simkin et al. 2015). Similarly, the presence of a hyperoxic 
microenvironment causes delayed wound closure with a corresponding extended histolytic phase 
and increased level of wound closure (Sammarco et al. 2014). 
Figure 1 displays the bone volume progression after a distal, P3 amputation of untreated 
(control) mice vs Dermabond-treated mice, obtained from Simkin et al. 2015. The application of 
Dermabond to the wound site clearly reduced the level of degeneration (loss of bone volume) 
and regeneration (gain of bone volume). 
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Figure 1. Results from Simkin et al. 2015, which were the basis for the use of Dermabond treated 
digits as the positive control for this experiment. These results display the average normalized (to 
the 0 DPA) bone volume of digits at 7, 10, 12, 14, 17, 21 and 28 DPA. The control sample shows 
how bone volume normally changes in an untreated sample. In A, it is apparent that the samples 
treated with Dermabond experienced significantly less degeneration and regeneration than the 
control samples. In D, the Dermabond treated digits were divided into Group A and Group B. 
Group A digits were chosen by a visual analysis of a phenotypic difference from the control 
samples, while Group B digits were those that underwent a regenerative process much more 
similar to that of the control. 
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CHAPTER II 
METHODS 
A selection of female mice will be exposed to the anesthetic agent isoflurane in a 
controlled environment until unconscious. Following amputation at the distal tip of the third 
phalangeal digit of the second, third and fourth toes on both hind limbs, 10 microliters of CVS 
liquid bandage will be applied to the wound site and then be re-applied each of the next two 
days. Digits will be collected 2,3,4,5, and 7 DPA. Amputated digits will be fixed, processed, and 
serially sectioned. One slide from each digit will be stained with Mallory trichrome to observe 
the overall morphology. The second slide will be subject to a dual immunohistochemical assay 
of Edu, which highlights proliferating cells, and Hif1𝛼𝛼, which is an indicator of a hypoxic 
microenvironment. Micro CT (μCT) scans of all subjects are taken at designated time points and 
edited using BoneJ, an ImageJ program plugin. Images will then be viewed using ImageJ’s 3D 
viewer plugin to visualize morphological changes in a three dimensional perspective. Bone 
volume is computed using the BoneJ volume fraction plugin and documenting differences in 
both bone volume and length throughout the period of regeneration are integral to understanding 
the extent of regeneration/degeneration elicited by the application of both treatments (Doube et 
al. 2010). 
Three trials were performed in this study, each differing in number of applications. In the 
first round, digits were treated with three applications of CVS-LB and evaluated histologically. 
Digits that were subject to μCT analysis were treated with only one application. A second 
iteration was done, this time including Dermabond. Digits were treated with three applications of 
either CVS-LB or Dermabond and stained with Hypoxyprobe to track regions of hypoxia. μCT 
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analysis was done for only the CVS-LB samples. The first two iterations of this project served to 
guide studies for the third trial involving the wound closure devices and are not the focus of the 
paper; thus, the results of those experiments are located in the appendix. To confirm Simkin’s 
results, the third round of this study, which forms the basis of this paper, included volumetric 
analysis of both CVS-LB and Dermabond digits and number of applications remained the same. 
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CHAPTER III 
RESULTS 
Degradation and Regeneration 
To analyze bone degradation/regeneration, scans were taken at designated time points 
between -1 DPA to 28 DPA (Figure 2). Original digit morphology prior to amputation is shown 
in the first column of Figure 2, labeled as -1 DPA. Once amputated at a distal level, the digit 
normally undergoes degradation between 8-12 DPA and this is characterized by loss in bone 
volume. This is observed in the untreated (control) digits. Conversely, both CVS-LB and 
Dermabond samples experienced reduced degradation and regeneration within this time frame 
(4-12 DPA), although this reduction was more significant for Dermabond-treated samples. 
Figure 2. μCT Scans of Treated and Control Digits. These scans range from pre-amputation (-1 
DPA) to 28 DPA and show the progression of degeneration/regeneration in 3 separate digits that 
have been treated (CVS-LB or Dermabond) or left untreated to serve as controls. 
The next stage of analysis was a volumetric analysis of the data obtained through μCT 
scans. Each individual digit was tracked from 0-28 DPA, which enabled normalization of the 
data by dividing each obtained digit volumes by that particular digit’s volume at 0 DPA. Figure 3 
displays the basic data obtained from this study. Graph A reveals that digits treated with CVS- 
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LB experienced more degradation than digits treated with Dermabond, while both experienced 
less degradation than the control digits. The CVS-LB average volumes were highly comparable 
to the Dermabond volumes obtained in Simkin’s experiment, and the Dermabond samples 
experienced even less degeneration than Simkin’s Dermabond treated digits. Graph B displays 
the control data and the Group A data for both Dermabond treated samples and CVS-LB treated 
samples. Group A consists of digits that stayed within 20% of their 0 DPA volume for the entire 
28 day period - they experienced reduced degeneration and regeneration. One of eight digits 
treated with CVS-LB and two of eight digits treated with Dermabond qualified as Group A 
digits. All of the digits that failed to qualify for Group A were designated as Group B. 
Figure 3. Overall Volumetric Results. A) This graph displays the overall average normalized 
bone volumes (with 95% confidence intervals shown by the vertical bars) for the CVS-LB, 
Dermabond, and control samples. B) This graph displays the Group A digits from both the CVS- 
LB and Dermabond samples; Group A digits are those that stayed within 20% of their 0 DPA 
bone volume for the entire 28 days. 
As Figure 4 depicts, the Group B for the CVS-LB was much more similar to the control 
than the Group B of Dermabond. However, it is important to note that even the Group B data for 
both treatment groups experienced statistically significantly less degeneration than that of the 
control. Additionally, the Group A data for both treatment groups was highly similar to Simkin’s 
Group A data, and the entire CVS-LB-treated Group A vs Group B graph looked was similar to 
the data obtained by Simkin et al. for Dermabond-treated digits. 
A B 
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Figure 4. CVS-LB-Specific and Dermabond-Specific Volumetric Results. A) The graph of the 
average, normalized bone volumes of Group A and Group B samples that were treated with 
CVS-LB. B) The graph of the average, normalized bone volumes of Group A and Group 
B samples that were treated with Dermabond. Digits that fell into Group A stayed within 20% of 
their 0 DPA volume for the entirety of the 28 days, and all other digits fell into Group B. 
Hypoxia and Wound Closure 
Images of digits that were collected at 2, 3, 4, 5, or 7 DPA and then stained with the 
Mallory Trichrome procedure or a Hif1-α/EdU immunohistochemical assay. All images were 
oriented so that the wound site is located on the right. The images that underwent a Mallory 
Trichrome stain are useful for identifying histology, while the images that underwent a Hif1- 
α/EdU immunohistochemical assay are used to identify areas of hypoxia and/or cellular 
proliferation. The structural characteristics to note in the Mallory stained images are the dark 
blue - bone; strong pink/red - scab and outer layer of skin; and light pink - epidermis. Mallory 
stains revealed if wound closure had occurred, defined by the dorsal and ventral wound 
epidermises connecting at the distal tip (Figure 5). 
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Figure 5. Secondary Amputation May Precede Wound Closure to Reveal A Secondary 
Amputation Plane. A) Wound closure can be observed when the ventral and dorsal edges of the 
epidermis (light pink) migrate across the amputated bone stump (as marked by the arrows). B) A 
secondary amputation occurs during the degradative phase, resulting in the cleavage and 
expulsion of the distal bone fragment. 
In each set of images in Figure 6 there is a row of images on the top (Panel A) with a 
corresponding row of images below it (Figure 6B).The images from Panel A were used to 
determine if wound closure had occurred. The images in each Panel B were used to identify 
areas of hypoxia - increased expression of “green” - and cell proliferation - expression of “red”. 
The nail (top), red blood cells (inside the center of the bone), and the fat pad (bottom) would 
auto fluoresce and were not taken into consideration. Due to the role of hypoxia in epidermal 
migration, Hif1-α was expressed at the distal portion of the epidermis prior to wound closure, as 
expected. Expression would spike at and shortly after wound closure, then slowly decrease (as 
seen in the lack of expression at 7 DPA in the Dermabond images of Figure 6). Cell proliferation 
appeared to generally only occur in 7 DPA images, if at all. This proliferative event occurs after 
7 DPA which presumably corresponds with the development of the blastema. Due to our lack of 
data post-7 DPA, it was hard to draw any connections between cellular proliferation and wound 
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closure/hypoxia, but it did appear that wound closure had to occur before any significant level of 
cell proliferation could occur. 
Figure 6. Images of Stained, Treated Digits. Each vertical pair is the same digit with a different 
staining procedure, but there is no association between digits horizontally other than that they 
underwent the same treatment. A) Images of samples stained with Mallory Trichrome, used to 
determine if wound closure had occurred. These samples showed positive wound closure at 3, 5 
and 7 DPA for the CVS-LB images, 4, 5, and 7 DPA for the Dermabond images, and 7 DPA for 
16 
the control images. B) Images of samples-which correspond to the Mallory stained sample above 
them-that underwent an EdU/Hif1-α immunohistochemical assay. Hypoxia is found at the 
leading edge of the epidermis throughout, and has widespread expression after wound closure. 
The apparent extreme distal expression of Hif1-α in the 2 DPA (all) and 4 DPA (CVS-LB, 
Control) immunos is autofluorescence from the scab, not hypoxia in the tissue at the wound. 
There was only slight expression of EdU in the wound site for the 7 DPA Dermabond and CVS- 
LB samples. 
The Mallory stained slide from every mouse digit was analyzed for wound closure, and 
the results were recorded in Table 1. It also contains the data from the previous two iterations of 
the CVS-LB/Dermabond experiment and those obtained from Simkin et al. 2015. In all three 
rounds, closure in both Dermabond and CVS-LB digits was identified as early as 3 DPA. Rates 
greatly varied from 9% (1/11) to 83% (5/6) for digits treated with CVS-LB and from 0% (0/5) to 
50% (3/6) in Dermabond samples. Closure occurred by 7 DPA in every sample in both rounds I 
and II, but only 1/5 (20%) of CVS-LB treated digits closed in round III at the same time point. 
(Table 1). 
Table 1. Rate of Wound Closure in Rounds I-III. 
ROUND I ROUND II ROUND III Simkin Data 
CVS-LB 
1 application 
CVS-LB 
1 
application 
DERM 
1 application 
CVS-LB 
3 applications 
DERM 
3 applications 
Control 
DERM 
1 
application 
2 DPA 0/5 (0%) 0/6 (0%) 0/6 (0%) 0/3 (0%) 1/3 (33%) 
3 DPA 5/6 (83%) 1/11 (9%) 3/6 (50%) 2/4 (50%) 0/5 (0%) ---- ---- 
4 DPA 0/6 (0%) 2/4 (50%) 0/4 (0%) 2/4 (50%) 
5 DPA 4/5 (80%) 0/12 (0%) 6/6 (100%) 1/5 (20%) 5/6 (83%) ---- ---- 
6 DPA ---- ---- ---- 0/5 (0%) 4/5 (80%) 
7 DPA 3/3 (100%) 3/3 (100%) 3/3 (100%) 1/5 (20%) 5/5 (100%) ---- ---- 
10 DPA 3/3 (100%) ---- ---- ---- ---- 
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CHAPTER IV 
CONCLUSION AND DISCUSSION 
The use of wound closure devices Dermabond and CVS-LB has shown to produce 
accelerated although variable levels of epidermal wound closure in all three rounds of this study 
(Table 1). With both treatments, wound closure was observed between 3-7 DPA; this is far faster 
than the average timeframe (8-12 DPA) for untreated digits. Timing of wound closure also 
coincided with expression of hypoxia, suggesting that it may be an indicator of wound closure. 
Only the results of samples treated with Dermabond have shown potential for a possible 
correlation with reduced degradation and regeneration. This could not be concluded with CVS- 
LB as volumetric analyses of all three rounds showed very little consistency. 
Differences of Dermabond/CVS-LB and Microbial Ramifications 
Although both CVS-LB and Dermabond are wound closure agents, they differ in 
composition. CVS-LB contains antiseptic/analgesic properties and establishes a microbial barrier 
to prevent infection. This may affect the microbial environment of the wound and contribute to 
the variability in responses to precocious wound closure of the Dermabond and CVS-LB treated 
samples. Disruption of the microflora can influence the histolytic immune response by affecting 
the differentiation of monocytes to macrophages rather than osteoclasts. Monocytes are 
leukocytes that are recruited by MCP-1 (among other things), a chemoattractant secreted by cells 
that regulate macrophage and monocytic activity at the site of inflammation or infection (Conti 
and DiGioacchino, 2001; Melgarejo 2008). 
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Further Studies 
When looking through the scope of regenerative medicine, the primary effect of wound 
closure devices such as Dermabond and CVS-LB is the inhibition of bone degradation. The 
osteoclasts responsible for bone degradation are formed by osteoclastogenesis in the days-to- 
week after the wound event; however, this process is presumably disrupted by the early wound 
closure event caused by the application of a wound closure agent, which leads to the decreased 
degradation. The process of wound closure itself, however, is still not fully known. More 
specifically, it is not known exactly what events trigger the epidermal migration which leads to 
the actual wound closure. For example, previous and ongoing studies have demonstrated that 
several treatments negatively affect wound closure, such as exposure to hyperbaric oxygen 
(effectively inhibiting a normally hypoxic microenvironment in the wound), although this can be 
recovered to a control-like wound closure rate by the application of Dermabond (Simkin et al. 
2015). Mice that had the nerves of the amputated toes removed did not experience wound closure 
at any point, even with the application of Dermabond (unpublished data). Similarly, hindlimb 
unloaded mice do not experience any acceleration to wound closure rates when Dermabond is 
applied post-amputation (unpublished data). Addition of the bisphosphonate clodronate severely 
inhibits the function of osteoclasts (Simkin 2017). If macrophages are eliminated from the 
wound site, wound closure and regeneration as a whole are entirely eliminated (Simkin 2017). 
While there are many questions yet to be answered about the wound closure process, one 
potential starting point would be to use Keratin 17 as an immunohistochemical wound marker to 
attempt to find any differences in the “wound identifying” behaviors between control digits, 
CVS-LB treated digits, and Dermabond-treated digits. Furthermore, replicating this study with 
an addition of CVS-LB’s active ingredients, benzethonium chloride (0.2%) and dyclonine 
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hydrochloride (0.75%) in addition to Dermabond treatment may help illustrate whether the two 
wound closure devices’ differential response can be attributed to analgesic agents found only in 
CVS-LB. 
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 APPENDIX 
Figure S1. This graph compares the average relative bone volumes of CVS-LB treated digits for each iteration of the experiment. 
Round I saw reduced degeneration, but incredibly large levels of regeneration, Round II was very similar to the control volumes, and 
Round III saw slightly decreased levels of degeneration and regeneration. Overall, CVS-LB application led to decreased degeneration, 
but had wildly inconsistent results. 
